EIDB close up lab shot

HIV Research


MHRP and collaborators recently launched a Phase 1 trial in Thailand that will evaluate two HIV vaccine candidates with and without the Army's novel ALFQ adjuvant to gain insight into late boosting strategies and the effects of fractional dosing.

  • Doctor consults with volunteer

    MHRP's acute HIV infection (AHI) cohorts provide insight into critical early days after infection. These MHRP-led studies continue to expand the field’s knowledge of immune responses in acute infection, expose mechanisms for treatment and cure, and inform rational design of vaccines and other interventions.

  • Backlit kneeling soldier

    MHRP's Department of Epidemiology and Threat Assessment conducts research on the epidemiology of HIV and other infectious diseases that threaten the readiness of U.S. and allied military forces. This research informs countermeasure development, and policy development and public health practices to decrease the rates of HIV and other STIs in the military.